Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials

Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials

We measured immunosuppression at myeloma diagnosis and assessed the impact on survival in 5826 UK myeloma trial patients. Polyclonal immunoglobulin levels were below normal in 85% of patients and above normal in only 0.4% of cases for IgA, 0.2% for IgM and no cases for IgG. Immunoparesis had a great...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Jennifer Heaney, John P. Campbell, Gulnaz Iqbal, David A. Cairns, Alex Richter, J. A. Child, Walter M. Gregory, Graham Jackson, Martin Kaiser, Roger G. Owen, Faith E. Davies, Gareth J. Morgan, Janet Dunn, Mark T. Drayson
Fformat: Artigo
Iaith:Saesneg
Cyhoeddwyd: 2018
Mynediad Ar-lein:https://doi.org/10.1038/s41375-018-0163-4
https://www.nature.com/articles/s41375-018-0163-4.pdf
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Rhyngrwyd

https://doi.org/10.1038/s41375-018-0163-4
https://www.nature.com/articles/s41375-018-0163-4.pdf

Eitemau Tebyg